兽用抗生素/抗生素市场规模、份额、成长分析，按类型、按交付、按动物、按地区 - 行业预测，2025-2032

2023年兽用抗生素和抗菌药物市场规模为46.2亿美元，从2024年的47.8亿美元增长到2032年的63亿美元，并且预计在预测期内（2025-2032年）将会增长。率为3.5%。

截至2023年10月，全球兽用抗生素和抗菌药物市场对动物用药品产业至关重要，这主要是由动物性蛋白质需求激增所推动的。世界人口的成长和可支配收入的增加导致肉类、牛奶和鸡蛋的消费量增加，从而导致畜牧业产量增加。这种增长需要使用抗生素和抗菌剂来预防和治疗牲畜传染病。此外，呼吸道和胃肠道感染疾病感染疾病盛行率的上升强调了有效疾病管理的必要性。人们对动物福利和预防通用感染疾病传播的兴趣日益浓厚，进一步强调了这些药物在确保动物健康、最佳生长和生产力方面的重要性。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

兽用抗生素/抗菌药物市场规模：依类型

• 市场概况
• 四环霉素
• 青霉素
• 磺胺类药物
• 大环内酯
• Aminoglycosides
• 林可酰胺
• Fluoroquinolones
• 头孢菌素
• 其他抗菌剂和抗生素

按交付量分類的兽用抗生素/抗菌药物市场规模

• 市场概况
• 预混合料
• 口服粉剂
• 口服液
• 注射
• 其他的

兽用抗生素/抗菌药物市场规模：依动物分类

• 市场概况
• 食用动物
  • 牛
  • 猪
  • 家禽
  • 绵羊和山羊
  • 其他食用动物
• 伴同性动物
  • 狗
  • 猫
  • 马
  • 其他宠物

兽用抗生素/抗菌药物市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
• 收益与前一年同期比较（2022-2024）

主要企业简介

• Zoetis Inc.（USA）
• Merck & Co., Inc.（USA）
• Elanco Animal Health Incorporated（USA）
• Boehringer Ingelheim International GmbH（Germany）
• Ceva Sante Animale（France）
• Virbac（France）
• Vetoquinol（France）
• Bayer AG（Germany）
• Novartis AG（Switzerland）
• Eli Lilly and Company（USA）
• Sanofi（France）
• Intervet Inc.（Netherlands）
• Alltech（Ireland）
• Huvepharma（Bulgaria）
• Kemin Industries（USA）
• Novus International（USA）
• Biomin Holding GmbH（Austria）
• ADM Animal Nutrition（USA）
• Adisseo（France）
• DSM（Netherlands）

结论和建议

Animal Antibiotics and Antimicrobials Market size was valued at USD 4.62 Billion in 2023 and is poised to grow from USD 4.78 Billion in 2024 to USD 6.3 Billion by 2032, growing at a CAGR of 3.5% during the forecast period (2025-2032).

As of October 2023, the global animal antibiotics and antimicrobials market is crucial to the veterinary pharmaceutical sector, primarily driven by the surging demand for animal protein. The increase in the global population and growing disposable incomes has led to higher consumption of meat, milk, and eggs, consequently boosting livestock production. This growth necessitates the use of antibiotics and antimicrobials for the prevention and treatment of infectious diseases among animals. Additionally, the rising prevalence of conditions such as respiratory and gastrointestinal infections emphasizes the need for effective disease management. The heightened focus on animal welfare and the prevention of zoonotic disease transmission further underscores the importance of these pharmaceuticals in ensuring animal health, optimal growth, and productivity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Animal Antibiotics And Antimicrobials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Animal Antibiotics And Antimicrobials Market Segmental Analysis

Global Animal Antibiotics And Antimicrobials Market is segmented by type, delivery, animal and region. Based on type, the market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins and other antimicrobials and antibiotics. Based on delivery, the market is segmented into premixes, oral powder, oral solution, injection and others. Based on animal, the market is segmented into food-producing animals and companion animals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market is significantly driven by the emergence of infectious diseases in livestock, including avian influenza, foot-and-mouth disease, and swine fever. These outbreaks highlight the critical need for effective antibiotics and antimicrobials to manage and prevent disease proliferation. The potential economic fallout from such epidemics spurs increased demand for these products, especially in areas where these diseases are frequently encountered. This demand is primarily fueled by the urgent need to safeguard animal health and ensure sustained productivity within the livestock sector, making these pharmaceuticals essential for maintaining the integrity of animal farming operations.

Restraints in the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market faces significant restraints due to changing consumer preferences towards antibiotic-free products. As awareness around food safety and sustainability continues to grow, there is a rising demand for animal products that do not involve the use of antibiotics. This shift in consumer behavior has prompted producers to transition toward antibiotic-free production methods, negatively affecting the demand for traditional animal antibiotics and antimicrobials. In their efforts to align with market trends and meet consumer expectations, producers are increasingly exploring alternative strategies for disease prevention and growth promotion in livestock, emphasizing sustainability and the reduction of antibiotic use.

Market Trends of the Animal Antibiotics And Antimicrobials Market

The Animal Antibiotics and Antimicrobials market is witnessing a significant trend towards the adoption of antibiotic alternatives, fueled by growing concerns over antimicrobial resistance (AMR) and its implications for both animal and human health. Regulatory pressures, heightened consumer awareness, and industry initiatives are driving the reduction of traditional antibiotic use in livestock production. Consequently, alternatives such as probiotics, prebiotics, phytogenics, and vaccines are emerging as effective solutions to promote animal well-being while minimizing AMR risks. This shift reflects a broader commitment within the industry to enhance animal health, optimize production efficiency, and adhere to responsible usage practices in veterinary medicine, shaping the future of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Animal Antibiotics And Antimicrobials Market Size by Type & CAGR (2025-2032)

• Market Overview
• Tetracyclines
• Penicillins
• Sulfonamides
• Macrolides
• Aminoglycosides
• Lincosamides
• Fluoroquinolones
• Cephalosporins
• Other Antimicrobials And Antibiotics

Global Animal Antibiotics And Antimicrobials Market Size by Delivery & CAGR (2025-2032)

• Market Overview
• Premixes
• Oral Powder
• Oral Solution
• Injection
• Others

Global Animal Antibiotics And Antimicrobials Market Size by Animal & CAGR (2025-2032)

• Market Overview
• Food-Producing Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep And Goats
  • Other Food-Producing Animals
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals

Global Animal Antibiotics And Antimicrobials Market Size & CAGR (2025-2032)

• North America (Type, Delivery, Animal)
  • US
  • Canada
• Europe (Type, Delivery, Animal)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Delivery, Animal)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Delivery, Animal)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Delivery, Animal)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intervet Inc. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alltech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomin Holding GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM Animal Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adisseo (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations